TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.68$ +9.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACTU
Line item 2022 2023 2024 2025
– -85.4% +211.1% +50.6%
– -85.4% +207.4% +48.2%
– -85.5% +192.1% +52.3%
– -85.5% +192.1% +52.3%
– +1,716.1% -91.0% -33.7%
– +59.3% +27.2% -35.2%
– +60.6% -43.9% -20.7%
– -771.7% – +7,505.6%
– – – –
– +0.0% +29.8% +7.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?